Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

Overview of attention for article published in BMC Musculoskeletal Disorders, December 2005

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,872 followers.

@niamhie53 https://t.co/ZmZzelnd7h Then a larger trial comparing lots of doses to diclofenac in OA = recommended initial dose of 30mg as many got benefit at that dose. [Contrast that with acute gout dose of 120mg daily]

10 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.